Biotechnology Investment Forum
Against the backdrop of profound changes in the medical field, biotechnology is undergoing continuous industrial restructuring, leading to a recent explosive development in the industry. Various emerging technologies are constantly emerging, and innovative biotech companies have sprung up like mushrooms after rain. The continuous heat in the investment and financing market confirms that the development of the biotechnology sector is in full swing and has great potential for the future. Under the new situation of the development of the biotechnology industry: What is the current state of investment and financing in this field? What emerging tracks are worth paying attention to? How do biotech companies choose the path to listing? These questions have become hot topics of concern for every industry participant.
For this reason, Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") is launching the Biotechnology Investment Forum on the occasion of the 16th Frost & Sullivan Global Growth, Innovation and Leadership Summit, inviting authoritative experts in the field, including leading biotech enterprises, well-known investment institutions, and listed intermediary teams, to jointly interpret the future investment direction of the industry and discuss the key factors for enterprise growth and capital market success.
Conference scale
90 - 100 people
Conference topics
Review and outlook of the biopharmaceutical investment and financing market in 2021
Inventory of emerging biotechnology investment and financing tracks - Synthetic biology
White paper release - Insights into the CDMO market and trends in China
Diversified paths for biotech companies to go public
Organizational structure
Sponsoring units
Sponsored units
Co-sponsoring units
The official registration entrance for conference attendees has been opened
Book now
